Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-07-02T04:47:04.840Z Has data issue: false hasContentIssue false

P-02 - use of Codeine Containing Medicines by Irish Psychiatric Patients Before and After the Introduction of Regulations on Their Supply

Published online by Cambridge University Press:  15 April 2020

V.I. Agyapong
Affiliation:
Department of Psychiatry, University of Dublin, Trinity College, Dublin, Ireland
K. Sighn
Affiliation:
Department of Psychiatry, St Patrick's University Hospital, Dublin, Ireland
M. Savage
Affiliation:
Department of Psychiatry, St Patrick's University Hospital, Dublin, Ireland
T. Thekiso
Affiliation:
Department of Psychiatry, St Patrick's University Hospital, Dublin, Ireland
M. Finn
Affiliation:
Department of Psychiatry, St Patrick's University Hospital, Dublin, Ireland
C.K. Farren
Affiliation:
Department of Psychiatry, University of Dublin, Trinity College, Dublin, Ireland
D. McLoughlin
Affiliation:
Department of Psychiatry, University of Dublin, Trinity College, Dublin, Ireland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

On the 1st of August 2010 guidelines aimed at ensuring the safe supply of over-the -counter codeine containing medicinal products came to force in Ireland.

Objectives

The study aimed to examine the frequency of use as well as reasons for the use of non-prescription codeine containing medicines in an Irish psychiatric population before and after the introduction of regulations on the supply of codeine containing medicines.

Methods

Self administered questionnaires were designed and administered to patients before and after the introduction of guidelines regulating the sale of non-prescribed codeine containing medicines in Ireland. The results were compiled and analysed using descriptive statistics and chi-square test.

Results

Significantly more patients reported that they often or regularly used codeine containing medicines before the introduction of the regulation compared to the period after that(33.3% vs. 17.4%, x2 = 6.354, p = 0.01). Significantly more patients also reported that others had expressed concerns about the frequency with which they used codeine containing medicines before the introduction of the regulation compared to the period after the introduction of the regulation (15.5% vs. 4.8%, x2 = 7.29, p = 0.03). Finally, significantly more patients stated that they would use codeine containing medicines either for the ‘feel good’ effect or to curb cravings before the introduction of the regulation than after the introduction of the regulation (15.9% vs. 1.9%, p = 0.00).

Conclusion

Tight regulations on the supply of non-prescription codeine containing medicines have the potential to reduce the abuse of such medicine among psychiatric patients in general.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.